Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Additional clinical data support the potential of DepoCyt in neoplastic meningitis

Oct. 25, 1996

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Cholestyramine treatment of peri-anal irritation in an infant

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Gensia turns over development of Geomatrix nifedipine product

Oct. 25, 1996

Rhone-Poulenc Rorer submits sNDA for new Tilade formulation

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...